Levon M. Khachigian* Pages 1 - 8 ( 8 )
Drug repurposing, put simply, is the process of developing existing or abandoned drugs for a different disease. Repurposing can circumvent higher costs and times associated with conventional drug discovery strategies because toxicity and pharmacokinetics profiles are typically already established. This brief review focuses on efforts to repurpose drugs for skin cancer and includes the reuse of antihypertensives, anthelmintics and antifungals among a range of other medicines. Repurposing not only ushers promising known drugs for new indications, the process of repurposing can uncover new mechanistic insights in the pathogenesis of disease and uncover new opportunities for pharmaceutical intervention.
Drug Repurposing, Drug Repositioning, Melanoma, Skin Cancer, Cancer, Disease
Vascular Biology and Translational Research, School of Medical Sciences, Faculty of Medicine, University of New South Wales,Sydney NSW 2052